Heterotopic ossification (HO) is the pathological process of bone formation in non-osseous tissues following trauma and/or surgical intervention. Following traumatic injury, cellular and hormonal signals from the site of injury, a supply of mesenchymal cells and the appropriate tissue microenvironment are all among the potential factors that could contribute to development of HO in injured tissues (1). Prophylactic radiation therapy (RT) is commonly used to reduce the risk of HO after open reduction and internal fixation (ORIF) of traumatic acetabular fractures (TAFs); heterotopic ossification after operative treatment of the hip using a posterior surgical approach has been reported in up to 50% of such patients (2). Radiation therapy presumably decreases the risk of HO by inhibiting the proliferation of pluripotential mesenchymal cells that could potentially differentiate into osteoblastic stem cells and is usually administered postoperatively, within 72 h of surgery (3-5). However, preoperative RT has also been used in these situations (6)(7)(8). In a recent meta-analysis reporting the incidence of HO after TAF status post ORIF, it was reported that the incidence of HO formation after RT prophylaxis 461 This article is freely accessible online.